Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1985-07-09
1987-10-27
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514554, 514563, 560170, 562567, 26050111, C07C10348, A61K 3122
Patent
active
047030615
ABSTRACT:
A compound which is 4-(3,5-dihydroxy-3-methylpentylamide)butyric acid or its pharmaceutically acceptable salt or ester; this compound being produced by reacting a salt or an ester of gamma-aminobutyric acid with beta-hydroxy-beta-methyl-delta-valerolactone, and as required, converting the resulting compound in the form of a salt or ester to a free acid, or as required, converting the resulting compound in the form of a free acid to its pharmaceutically acceptable salt or ester; and useful as a medicament for preventing or treating an impediment in cerebral function.
REFERENCES:
patent: 2234680 (1941-03-01), Moore
patent: 2271872 (1942-02-01), Mitchell
patent: 2414682 (1947-01-01), Williams
patent: 2442143 (1948-05-01), Pickel
patent: 2848489 (1958-08-01), Kagan
patent: 2856421 (1958-10-01), Hasbrouck
Burger, "Medical Chemistry," Part II, 3rd Ed., pp. 1196-1197 & 1222-1227 (1970).
Kameyama Tsutomu
Kitamura Jiro
Mizuno Masao
Takigawa Tetsuo
Kuraray Co. Ltd.
Shippen Michael L.
LandOfFree
Gamma-aminobutyric acid derivatives, process for production ther does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-aminobutyric acid derivatives, process for production ther, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-aminobutyric acid derivatives, process for production ther will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1272516